Competitive Technologies Licenses Homocysteine Assay to Bayer
Bayer Homocysteine Assays Carry Pass-Through License to Customers
Under the accord reached, Bayer is granted a license under the CTT patent and will pay royalties on sales of Bayer homocysteine assays currently available on the ADVIA Centaur(R) Immunoassay System and the ACS: 180(R) SE Automated Chemiluminescence System.
Customers who purchase Bayer homocysteine assays will be covered by the Bayer license from CTT. Bayer customers such as hospital and commercial laboratories that have separate homocysteine licenses from CTT will be relieved of their obligation to pay royalty on reportable homocysteine results obtained using the Bayer assay by virtue of the royalty paid by Bayer to CTT.
Furthermore, the arrangement negotiated with CTT releases any obligation on the part of Bayer customers to pay royalties to CTT for homocysteine results obtained using Bayer assays in the past. And, CTT has agreed not to pursue royalties from any current or future Bayer customer with respect to past homocysteine results obtained using assays purchased from other diagnostic companies -- CTT intends to pursue such royalties against the supplier diagnostic companies directly and reserves its rights against these supplier diagnostics companies.
The settlement and license does not relieve Bayer customers for royalties on past or future assays for methylmalonic acid. Customers should contact CTT for a license to perform such assays.
The homocysteine patent is derived from discoveries made by CTT's clients, Drs. Robert Allen and Sally Stabler from the University of Colorado and the late Dr. John Lindenbaum from Columbia University.
Other news from the department research and development
Most read news
More news from our other portals
See the theme worlds for related content
Topic world Diagnostics
Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.
Topic world Diagnostics
Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.